Showing results (491-500 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 29, 2021
Branched Multipeptide-combined Adjuvants Potentially Improve the Antitumor Effects on GlioblastomaThi-Anh-Thuy Tran, Young-Hee Kim, Shin Jung, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 14, 2021
Expanded Tumor-infiltrating Lymphocytes From Soft Tissue Sarcoma Have Tumor-specific FunctionJohn E Mullinax, MacLean Hall, Matthew Beatty, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
Different Response to Immunotherapy According to Melanoma Histologic SubtypeLaura Pala, Fabio Conforti, Eleonora Pagan, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 10, 2009
IL-18 paradox in pancreatic carcinoma: elevated serum levels of free IL-18 are correlated with poor survivalAnna Carbone, Barbara Vizio, Anna Novarino, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 10, 2009
Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacityIl-Kang Na, Anne Letsch, Manuel Guerreiro, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 10, 2009
Selective transduction of mature DC in human skin and lymph nodes by CD80/CD86-targeted fiber-modified adenovirus-5/3Rieneke van de Ven, Jelle J Lindenberg, Dinja Oosterhoff, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 13, 2011
Wildtype p53-specific antibody and T-cell responses in cancer patientsAnders Elm Pedersen, Anette Stryhn, Sune Justesen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1Gheath Alatrash, Yoko Ono, Anna Sergeeva, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
Increase of circulating B7-H4-expressing CD68+ macrophage correlated with clinical stage of lung carcinomasCheng Chen, Yi-Bei Zhu, Yu Shen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Imatinib sensitizes T-cell lymphocytes from chronic myeloid leukemia patients to FasL-induced cell death: a brief communicationLaurence Legros, Nathalie Ebran, Emmanuelle Stebe, et al.Pageof 176